EDMOND DE ROTHSCHILD ASSET MANAGEMENT (FRANCE) - 30 Jun 2025 SCHEDULE 13G/A Report for Pacific Biosciences of California, Inc. Common Stock (PACB)

Filing Manager
EDMOND DE ROTHSCHILD ASSET MANAGEMENT (FRANCE)
Reporting Manager
EDMOND DE ROTHSCHILD ASSET MANAGEMENT (FRANCE)
Security
Pacific Biosciences of California, Inc. Common Stock
Symbol
PACB
Shares outstanding
297,026,667 shares
Disclosed Ownership
13,366,200 shares
Ownership
4.5%
Form type
SCHEDULE 13G/A
Filing time
24 Jul 2025, 13:54:30 UTC
Date of event
30 Jun 2025
SEC
View on sec.gov

Key filing fact

EDMOND DE ROTHSCHILD ASSET MANAGEMENT (FRANCE) disclosed 4.5% ownership in Pacific Biosciences of California, Inc. Common Stock (PACB) on 30 Jun 2025.

Key facts

  • EDMOND DE ROTHSCHILD ASSET MANAGEMENT (FRANCE) filed SCHEDULE 13G/A for Pacific Biosciences of California, Inc. Common Stock (PACB).
  • Disclosed ownership: 4.5%.
  • Date of event: 30 Jun 2025.

Change

  • No earlier schedule filing is available for direct comparison.
  • Current filing was accepted on 24 Jul 2025, 13:54.

Research use

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Evidence

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting persons

Reporting managers (3)

Names, ownership, voting power, signatures, titles, and CIKs as disclosed in this Schedule 13D/G filing.

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
EDMOND DE ROTHSCHILD ASSET MANAGEMENT (FRANCE) 4.5% 13,366,200 0 12,081,800 /s/ Benjamin Melman Benjamin Melman / Global Chief Investment Officer
EDMOND DE ROTHSCHILD ASSET MANAGEMENT (LUXEMBOURG) 4% 12,081,800 0 12,081,800 /s/ Marc Fohr Marc Fohr / COMEX Member
EDMOND DE ROTHSCHILD FUND 4% 12,081,800 0 12,081,800 /s/ Flavien Duval Flavien Duval / Member of the Board
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .